Dr Aldred’s research combines her wide-ranging experience in inherited diseases and cancer genetics to the study of PAH and Hereditary Hemorrhagic Telangiectasia (HHT). PAH is a potentially fatal disorder characterized by proliferative changes in the vessels of the lungs, leading to a sustained elevation in pulmonary artery pressure.
Research
- Genetics of Pulmonary Hypertension and Hereditary Hemorrhagic Telangiectasia
- Precision Health
Her work now focuses on characterizing the molecular basis for these changes and their functional role in the disease process.
